aica ribonucleotide has been researched along with Muscle Relaxation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, C; Brockhoff, M; Castets, P; Chojnowska, K; Eickhorst, C; Erne, B; Frank, S; Furling, D; Rion, N; Rüegg, MA; Sinnreich, M; Wiktorowicz, T | 1 |
| Arner, A; Davis, B; Rahman, A | 1 |
2 other study(ies) available for aica ribonucleotide and Muscle Relaxation
| Article | Year |
|---|---|
Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I.
Topics: Adult; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Female; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Mutant Strains; Middle Aged; Multiprotein Complexes; Muscle Fibers, Skeletal; Muscle Relaxation; Myotonic Dystrophy; Myotonin-Protein Kinase; Ribonucleotides; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2017 |
AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signaling and inhibits NO-induced relaxation.
Topics: Adrenergic Agonists; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Membrane Potentials; Mice; Mice, Inbred C57BL; Muscarinic Agonists; Muscle Relaxation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Phenylephrine; Protein Kinase C; Protein Kinase Inhibitors; Ribonucleotides; RNA, Messenger; Signal Transduction; Urinary Bladder | 2012 |